New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Stereotactic radiosurgery found to be effective for treatment of vestibular schwannomas in neurofibromatosis type 2

Stereotactic radiosurgery found to be effective for treatment of vestibular schwannomas in neurofibromatosis type 2

byWolters Kluwer HealthCredit:Neurosurgery(2023). DOI: 10.1227/neu.0000000000002436Vestibular schwannomas related to neurofibromatosis type 2 (NF2) are difficult to manage and are so
World medicine December 12,2023
Stereotactic radiosurgery found to be effective for treatment of vestibular schwannomas in neurofibromatosis type 2

Stereotactic radiosurgery found to be effective for treatment of vestibular schwannomas in neurofibromatosis type 2

byWolters Kluwer HealthCredit:Neurosurgery(2023). DOI: 10.1227/neu.0000000000002436Vestibular schwannomas related to neurofibromatosis type 2 (NF2) are difficult to manage and are so
World medicine December 12,2023
Historic redlining practices cast a long shadow on cancer screening rates

Historic redlining practices cast a long shadow on cancer screening rates

byAmerican College of SurgeonsAccording to a new study published in theJournal of the American College of Surgeons, redlining was associated with lower odds of hitting national screening t
World medicine December 12,2023
Historic redlining practices cast a long shadow on cancer screening rates

Historic redlining practices cast a long shadow on cancer screening rates

byAmerican College of SurgeonsAccording to a new study published in theJournal of the American College of Surgeons, redlining was associated with lower odds of hitting national screening t
World medicine December 12,2023
Ion therapy safe and efficacious for the treatment of skull base cancer: Study

Ion therapy safe and efficacious for the treatment of skull base cancer: Study

by EBG MedAustron GmbHProton beam therapy plan for skull base chordoma showing steep dose-gradient with sharp dose fall off in proximity of the optic pathways and brainstem. Credit:Cancers
World medicine December 12,2023
Ion therapy safe and efficacious for the treatment of skull base cancer: Study

Ion therapy safe and efficacious for the treatment of skull base cancer: Study

by EBG MedAustron GmbHProton beam therapy plan for skull base chordoma showing steep dose-gradient with sharp dose fall off in proximity of the optic pathways and brainstem. Credit:Cancers
World medicine December 12,2023
Understanding how aggressive thyroid cancer evolves

Understanding how aggressive thyroid cancer evolves

by Olivia Dimmer,Northwestern UniversityGraphical abstract. Credit:Journal of Clinical Investigation(2023). DOI: 10.1172/JCI169653Northwestern Medicine scientists have shed new light
World medicine December 12,2023
Understanding how aggressive thyroid cancer evolves

Understanding how aggressive thyroid cancer evolves

by Olivia Dimmer,Northwestern UniversityGraphical abstract. Credit:Journal of Clinical Investigation(2023). DOI: 10.1172/JCI169653Northwestern Medicine scientists have shed new light
World medicine December 12,2023
Lorazepam treatment may be linked to worse outcomes for pancreatic cancer patients

Lorazepam treatment may be linked to worse outcomes for pancreatic cancer patients

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainPatients with pancreatic cancer who took the benzodiazepine lorazepam (Ativan), commonly prescribed to treat anxiety d
World medicine December 12,2023
Lorazepam treatment may be linked to worse outcomes for pancreatic cancer patients

Lorazepam treatment may be linked to worse outcomes for pancreatic cancer patients

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainPatients with pancreatic cancer who took the benzodiazepine lorazepam (Ativan), commonly prescribed to treat anxiety d
World medicine December 12,2023
Structural framework for tumors also provides immune protection

Structural framework for tumors also provides immune protection

byMedical College of Georgia at Augusta UniversityDr. Yan Cui, immunologist in the Georgia Cancer Center and Department of Biochemistry and Molecular Biology at the Medical College of Georgia. C
World medicine December 11,2023
Structural framework for tumors also provides immune protection

Structural framework for tumors also provides immune protection

byMedical College of Georgia at Augusta UniversityDr. Yan Cui, immunologist in the Georgia Cancer Center and Department of Biochemistry and Molecular Biology at the Medical College of Georgia. C
World medicine December 11,2023
Cancer: The immune system attacks tumors remotely

Cancer: The immune system attacks tumors remotely

byPasteur InstituteCredit: CC0 Public DomainHow does the immune system act to limit tumor development? Using in vivo imaging tools, scientists from the Institut Pasteur and Inserm described the
World medicine December 11,2023
Cancer: The immune system attacks tumors remotely

Cancer: The immune system attacks tumors remotely

byPasteur InstituteCredit: CC0 Public DomainHow does the immune system act to limit tumor development? Using in vivo imaging tools, scientists from the Institut Pasteur and Inserm described the
World medicine December 11,2023
Controlling CAR T cells with light selectively destroys skin tumors in mice

Controlling CAR T cells with light selectively destroys skin tumors in mice

byUniversity of California - San DiegoCredit: CC0 Public DomainBioengineers at the University of California San Diego have developed a control system that could make CAR T-cell therapy safer and
World medicine December 11,2023
Controlling CAR T cells with light selectively destroys skin tumors in mice

Controlling CAR T cells with light selectively destroys skin tumors in mice

byUniversity of California - San DiegoCredit: CC0 Public DomainBioengineers at the University of California San Diego have developed a control system that could make CAR T-cell therapy safer and
World medicine December 11,2023
Immune therapy reduces risk of recurrence in aggressive breast cancer

Immune therapy reduces risk of recurrence in aggressive breast cancer

byQueen Mary, University of LondonThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 by
World medicine December 11,2023
Immune therapy reduces risk of recurrence in aggressive breast cancer

Immune therapy reduces risk of recurrence in aggressive breast cancer

byQueen Mary, University of LondonThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 by
World medicine December 11,2023
Targeting stromal cells may help overcome treatment resistance in glioblastoma

Targeting stromal cells may help overcome treatment resistance in glioblastoma

byPerelman School of Medicine at the University of PennsylvaniaGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0The deadly brain cancer glioblastoma (GBM) is often resistant to chem
World medicine December 11,2023
Targeting stromal cells may help overcome treatment resistance in glioblastoma

Targeting stromal cells may help overcome treatment resistance in glioblastoma

byPerelman School of Medicine at the University of PennsylvaniaGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0The deadly brain cancer glioblastoma (GBM) is often resistant to chem
World medicine December 11,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com